<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000683643"><TermName>DBVE-PC</TermName><TermDefinition><DefinitionText>An abbreviation for a chemotherapy combination used with radiation therapy to treat childhood Hodgkin lymphoma. It includes the drugs doxorubicin hydrochloride (Adriamycin), bleomycin sulfate, vincristine sulfate, etoposide, prednisone, and cyclophosphamide. Also called ABVE-PC, ABVE-PC regimen,  and DBVE-PC regimen.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><SpanishTermName>DBVE-PC</SpanishTermName><SpanishTermDefinition><DefinitionText>Abreviatura del nombre de una quimioterapia combinada que se usa junto con radioterapia para tratar el linfoma de Hodgkin infantil. Contiene los medicamentos clorhidrato de doxorrubicina (Adriamycin), sulfato de bleomicina, sulfato de vincristina, etopósido, prednisona y ciclofosfamida.   También se llama ABVE-PC, régimen ABVE-PC,  y régimen DBVE-PC.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2010-09-24</DateFirstPublished><DateLastModified>2010-09-29</DateLastModified><RelatedInformation><RelatedDrugSummaryRef href="CDR0000683513">ABVE-PC</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
